An Antiviral Formulation with DNA Gyrase and RNA Dependent RNA Polymerase Suppressive Features As an Adjunct Treatment for Coronaviral Infections

In order to eliminate the disadvantages of the state of the art, an object of the invention is to cause permanent destruction in the structure and the function of the virus itself, owing to the tissue-selective increase in the production of nitric oxide (particularly in the tissues exposed to viral infection). Another object of the invention is to effectively inhibit the DNA synthesis capability of the viruses and also the ability of the viruses to transfer the DNA they synthesize into the healthy cells that they have not yet invaded. Another object of the invention is to support intracellular immunity by enhancing the TH1 immune reaction. In order to achieve the aforesaid advantages, the invention is a composition for antiviral use, said composition being obtained by the components selected from the group comprising 1-protopanaxatriol, methylpanaxadiol, methylprotobioside that are used individually or in combinations.